Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A reliable coding system to define screening prostate-specific antigen tests was developed in a case-control study.

Peter S Bunting1, Jan Neuman, Vivek Goel

  • 1Division of Biochemistry, Department of Pathology and Laboratory Medicine, University of Ottawa, Ontario, Canada. dsailhart@rivnet.net

Journal of Clinical Epidemiology
|May 10, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Analysis of upper tract urothelial carcinoma in the Asian population.

BJU international·2025
Same author

Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancer.

BJU international·2025
Same author

Author Correction: Atypical intraductal proliferation in prostate biopsy - a diagnostic grey zone with clinical implications.

Nature reviews. Urology·2025
Same author

Virtual versus in-person sexual rehabilitation for prostate cancer survivors: a retrospective cohort study comparing the Prostate Cancer Rehabilitation Clinic (PCRC) and the True North Sexual Health and Rehabilitation eClinic (SHAReClinic).

Sexual medicine·2025
Same author

Atypical intraductal proliferation in prostate biopsy - a diagnostic grey zone with clinical implications.

Nature reviews. Urology·2025

This study developed a reliable coding system for prostate-specific antigen (PSA) testing, including digital rectal examination (DRE) and transrectal ultrasound (TRUS). The system demonstrated high interobserver agreement, proving effective for case-control studies.

Area of Science:

  • Urology
  • Medical Informatics
  • Epidemiology

Background:

  • Prostate-specific antigen (PSA) testing is crucial for prostate cancer screening and diagnosis.
  • Accurate data abstraction from patient charts is essential for epidemiological studies.
  • Reliability of coding systems for PSA, digital rectal examination (DRE), and transrectal ultrasound (TRUS) needs validation.

Purpose of the Study:

  • To establish the reliability of a coding system for PSA, DRE, and TRUS data extraction.
  • To assess interobserver agreement for coding these diagnostic tests.
  • To validate the coding system within a population-based case-control study.

Main Methods:

  • Two investigators reviewed 448 chart abstractions from a prostate cancer screening case-control study.

Related Experiment Videos

  • Evaluated reliability for coding digital rectal examination (DRE), prostate-specific antigen (PSA), and transrectal ultrasound (TRUS).
  • Calculated interobserver agreement using kappa statistics for various parameters.

    • Main Results:

    • High interobserver agreement was achieved for DRE (94-97%) and PSA coding (91%).
    • Transrectal ultrasound (TRUS) coding reliability was also high at 87%.
    • Coding system accurately categorized PSA tests into screening (pure and symptomatic) and diagnostic.

    Conclusions:

    • A practical and reliable coding system for TRUS, DRE, and PSA has been developed.
    • This system is suitable for use in case-control studies investigating PSA screening.
    • Validated coding enhances the accuracy of epidemiological research in urology.